Free Trial

Acelyrin (SLRN) SEC Filings & 10K Form

Acelyrin logo
$2.27 0.00 (0.00%)
As of 05/21/2025

Recent Acelyrin SEC Filings

DateFilerForm TypeView
06/09/2025
12:50 PM
Acelyrin (Filer)
Form 15-12G
05/27/2025
7:56 AM
Acelyrin (Subject)
Trium Capital LLP (Filed by)
Form SCHEDULE 13D/A
05/23/2025
3:06 PM
Acelyrin (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:06 PM
Acelyrin (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:07 PM
Acelyrin (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:08 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
3:09 PM
Acelyrin (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2025
11:15 PM
Acelyrin (Filer)
Form EFFECT
05/21/2025
12:51 PM
Acelyrin (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
05/21/2025
8:24 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2025
3:20 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
1:46 PM
Acelyrin (Subject)
Form 425
04/30/2025
7:27 PM
Acelyrin (Subject)
Madison Avenue Partners, LP (Filed by)
Form SCHEDULE 13D
04/29/2025
8:09 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
04/21/2025
3:23 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
04/21/2025
5:30 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2025
5:31 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
04/21/2025
5:32 AM
Acelyrin (Subject)
Form 425
04/21/2025
6:41 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
04/04/2025
3:41 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
04/04/2025
3:22 PM
Acelyrin (Filer)
Form DEFM14A
04/04/2025
3:28 PM
Acelyrin (Filer)
Form DEFA14A
03/25/2025
5:06 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/19/2025
5:06 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
5:11 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:55 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:32 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/19/2025
3:12 PM
Acelyrin (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2025
5:02 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/14/2025
8:04 PM
Acelyrin (Subject)
Kim Mina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
8:37 AM
Acelyrin (Filer)
Form 8-A12B
03/13/2025
8:32 AM
Acelyrin (Subject)
Form 425
03/13/2025
8:12 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
4:58 PM
Acelyrin (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D/A
03/07/2025
11:49 AM
Acelyrin (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
03/06/2025
10:55 AM
Acelyrin (Subject)
Trium Capital LLP (Filed by)
Form SCHEDULE 13D
03/06/2025
5:03 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
03/06/2025
5:03 AM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2025
5:05 AM
Acelyrin (Subject)
Form 425
03/04/2025
8:05 AM
Acelyrin (Subject)
Form 425
03/04/2025
8:07 AM
Acelyrin (Subject)
Form 425
Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)

Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.

If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is
03/04/2025
8:12 AM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/27/2025
6:02 PM
Acelyrin (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13D/A
02/21/2025
5:03 AM
Acelyrin (Subject)
Form 425
02/14/2025
5:13 PM
Acelyrin (Subject)
CITADEL ADVISORS LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:45 AM
Acelyrin (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
02/10/2025
3:08 PM
Acelyrin (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SCHEDULE 13G/A
02/07/2025
4:00 PM
Acelyrin (Subject)
Form 425
02/07/2025
3:07 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/06/2025
7:36 PM
Acelyrin (Subject)
Form 425
02/06/2025
8:09 PM
Acelyrin (Subject)
Form 425
02/06/2025
8:40 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/06/2025
4:22 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
02/06/2025
4:19 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
4:21 PM
Acelyrin (Subject)
ALUMIS INC. (Filed by)
Form 425
01/31/2025
3:26 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
5:02 PM
Acelyrin (Issuer)
Kim Mina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
5:05 PM
Acelyrin (Issuer)
Mpofu Shephard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
4:58 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:34 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
4:17 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/24/2024
11:15 PM
Acelyrin (Filer)
Form EFFECT
11/22/2024
4:41 PM
Acelyrin (Issuer)
Murugan Amar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:26 PM
Acelyrin (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2024
3:01 PM
Acelyrin (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
11:13 AM
Acelyrin (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/08/2024
1:17 PM
Acelyrin (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/04/2024
9:56 AM
Acelyrin (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
10/24/2024
1:02 PM
Acelyrin (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
09/10/2024
12:49 PM
Acelyrin (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SC 13G
09/04/2024
7:36 PM
Acelyrin (Issuer)
Labrucherie Gil M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:18 PM
Acelyrin (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:14 PM
Acelyrin (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
8:40 AM
Acelyrin (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/19/2024
5:18 PM
Acelyrin (Issuer)
Becker Daniel J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLRN) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners